ATOSSA THERAPEUTICS, INC.: capex
| Value | {"amount": 51068, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2018-01-01 – 2018-03-31 |
| Status | current |
| Entity | ATOSSA THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:48:01.895087+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/a19cfcc0-d418-4cab-ae08-ca7392de721a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001437749-19-009666 · Open the official SEC filing →Retrieved: 2026-08-19T14:48:01.895087+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001488039/capex/2018-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/a19cfcc0-d418-4cab-ae08-ca7392de721a
History
- no predecessors — first report